Insulin aspart, recombinant Subcutaneous and Sodium Nitrite Injection
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Sodium Nitrite Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: sodium nitrite
Brand name:
Synonyms: Sodium Nitrite
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Sodium Nitroprusside
- Insulin aspart, recombinant Subcutaneous-Sodium Nitroprusside Injection
- Insulin aspart, recombinant Subcutaneous-Sodium nitroprusside Intravenous
- Insulin aspart, recombinant Subcutaneous-Sodium oxybate
- Insulin aspart, recombinant Subcutaneous-Sodium phenylacetate and benzoate Intravenous
- Insulin aspart, recombinant Subcutaneous-Sodium Phenylacetate and Sodium Benzoate
- Sodium Nitrite Injection-Insulin degludec
- Sodium Nitrite Injection-Insulin Degludec (U-100) Prefilled Pens
- Sodium Nitrite Injection-Insulin Degludec (U-100) Vials
- Sodium Nitrite Injection-Insulin Degludec (U-200) Prefilled Pens
- Sodium Nitrite Injection-Insulin degludec and liraglutide
- Sodium Nitrite Injection-Insulin degludec and liraglutide Subcutaneous